Edwards Lifesciences
1,206 hedge funds and large institutions have $36.6B invested in Edwards Lifesciences in 2025 Q1 according to their latest regulatory filings, with 122 funds opening new positions, 387 increasing their positions, 489 reducing their positions, and 124 closing their positions.
45% more call options, than puts
Call options by funds: $257M | Put options by funds: $178M
1.04% more ownership
Funds ownership: 85.24% → 86.28% (+1%)
0% more funds holding in top 10
Funds holding in top 10: 10 → 10 (0)
2% less first-time investments, than exits
New positions opened: 122 | Existing positions closed: 124
2% less capital invested
Capital invested by funds: $37.2B → $36.6B (-$602M)
2% less funds holding
Funds holding: 1,228 → 1,206 (-22)
21% less repeat investments, than reductions
Existing positions increased: 387 | Existing positions reduced: 489
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$509M |
| 2 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$304M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$284M |
| 4 |
Millennium Management
New York
|
+$230M |
| 5 |
Jennison Associates
New York
|
+$184M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$292M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$199M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$175M |
| 4 |
SFFS
Stonehage Fleming Financial Services
St. Helier,
Jersey
|
-$163M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$126M |
EW Hedge Fund Activity: Q1 2025 in Review
1,206 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q1 2025, worth a combined $36.6B — down 1.6% from $37.2B a quarter earlier.
Sellers outnumbered buyers: 124 funds closed out of EW and 122 opened new positions — a net loss of 2 holders — while 489 trimmed existing stakes and 387 added.
The largest buyer was JP Morgan Chase, adding an estimated $509M. The largest seller was Wellington Management Group, cutting an estimated $292M.
- 1,206 institutional investors held Edwards Lifesciences (EW) as of Q1 2025, down from 1,228 in Q4 2024.
- Funds reported $36.6B of Edwards Lifesciences stock for Q1 2025, down 1.6% quarter-over-quarter.
- 122 funds opened new Edwards Lifesciences positions in Q1 2025 and 124 closed out, a net change of -2 holders.
- The largest Edwards Lifesciences buyer in Q1 2025 was JP Morgan Chase, an estimated $509M added.
- The largest Edwards Lifesciences seller in Q1 2025 was Wellington Management Group, an estimated $292M sold.
Based on aggregated 13F filings for Q1 2025.